JANX Janux Therapeutics, Inc. - Common Stock
$16,27
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 6, 2026
Rango 52S
$12–$35
17% of range
Calificación del Analista
BUY
26 analysts
Precio Objetivo
$37
+128% upside
P/E (TTM)
-8.9
ROE
-11.7%
Margen de Beneficio Neto
-1136.2%
JANX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$16.27
Capitalización Bursátil
$982M
P/E (TTM)
-8.9
BPA (TTM)
$-1.83
Ingresos (TTM)
$10M
Rendimiento div.
—
ROE
-11.7%
Deuda/Capital
—
Rango 52S
$12 – $35
JANX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$10M
2020-12-31
→
2025-12-31
BPA
$-1.83
2021-12-31
→
2025-12-31
Flujo de caja libre
$-83M
2021-12-31
→
2025-12-31
Márgenes
-1136.2%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
JANX
Mediana de Pares
P/E (TTM)
-8.9
—
P/S (TTM) (P/V (TTM))
98.2
12.8
P/B (P/C)
1.0
3.4
Price / FCF (Precio / FCF)
-11.8
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
JANX
Mediana de Pares
Operating Margin (Margen Operativo)
-1576.7%
—
Net Profit Margin (Margen de Beneficio Neto)
-1136.2%
-294.4%
ROA
-11.0%
-31.3%
ROE
-11.7%
-38.1%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
JANX
Mediana de Pares
Current Ratio (Ratio corriente)
39.0
10.9
Quick Ratio (Ratio Rápido)
38.7
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
JANX
Mediana de Pares
Revenue YoY (Ingresos interanuales)
-5.5%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
5.1%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
JANX
Mediana de Pares
JANX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
26 analistas
- Compra fuerte 9 34,6%
- Compra 12 46,2%
- Mantener 4 15,4%
- Venta 1 3,8%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
16 analistas · 2026-08-17
Mediana
$32.00
Media
$37.06
Ahora
$16.27
Mín
$14.00
Máx
$75.00
Objetivo mediano
$32.00
+96,7%
Objetivo medio
$37.06
+127,8%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.09%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.35 | $-0.39 | 0.04% |
| 31 de marzo de 2026 | $-0.39 | $-0.54 | 0.15% |
| 31 de diciembre de 2025 | $-0.51 | $-0.66 | 0.15% |
| 30 de septiembre de 2025 | $-0.39 | $-0.63 | 0.24% |
| 30 de junio de 2025 | $-0.55 | $-0.48 | -0.07% |
| 31 de marzo de 2025 | $-0.38 | $-0.40 | 0.02% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | — |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | — |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | — |
| ODTX | — | — | — | — | — | — |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | — |
| CLYM | $191M | -4.5 | — | — | -34.6% | — |
| GERN | $845M | -10.2 | -60.2% | — | -34.4% | — |
| ANNX | $750M | -3.7 | — | — | -100.7% | — |
| SLDB | $445M | -2.8 | — | — | -79.5% | — |
| OLMA | $2.03B | -13.4 | — | — | -39.4% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 12
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $10M | $11M | $8M | $9M | $4M | $0 | |
| R&D Expense | $126M | $68M | $55M | $53M | $26M | $3M | |
| SG&A Expense | $42M | $41M | $26M | $22M | $10M | $2M | |
| Operating Income | $-158M | $-99M | $-73M | $-67M | $-33M | $-5M | |
| Other Non-op | $44M | $30M | $15M | $4M | $257.0K | $-2M | |
| Income Tax | $0 | $0 | $0 | · | · | · | |
| Net Income | $-114M | $-69M | $-58M | $-63M | $-33M | $-7M | |
| EPS (Basic) | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 | · | |
| EPS (Diluted) | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 | · | |
| Shares (Basic) | 61,966,999 | 53,751,480 | 44,016,283 | 41,469,631 | 23,530,252 | 233,726 | |
| Shares (Diluted) | 61,966,999 | 53,751,480 | 44,016,283 | 41,469,631 | 23,530,252 | · | |
| EBITDA | $-158M | $-99M | $-73M | $-67M | $-33M | · |
Balance general 21
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $52M | $431M | $19M | $51M | $36M | $8M | |
| Short-term Investments | $914M | $595M | $325M | $276M | $339M | $0 | |
| Receivables | $0 | · | $0 | $0 | $0 | $8M | |
| Prepaid Expense | $9M | $8M | $5M | $5M | $2M | $249.0K | |
| Current Assets | $976M | $1.03B | $349M | $332M | $377M | $16M | |
| PP&E (Net) | $4M | $5M | $7M | $7M | $1M | $155.0K | |
| PP&E (Gross) | $11M | $10M | $10M | $8M | $2M | $176.0K | |
| Accum. Depreciation | $7M | $5M | $3M | $972.0K | $131.0K | $21.0K | |
| Other Non-current Assets | $3M | $3M | $3M | $1M | $392.0K | $0 | |
| Total Assets | $1.00B | $1.06B | $380M | $364M | $380M | $16M | |
| Accounts Payable | $5M | $4M | $2M | $2M | $2M | $428.0K | |
| Accrued Liabilities | $18M | $12M | $7M | $8M | $4M | $751.0K | |
| Current Liabilities | $25M | $17M | $13M | $17M | $13M | $3M | |
| Capital Leases | $20M | $21M | $23M | $25M | $0 | $0 | |
| Total Liabilities | $45M | $39M | $36M | $43M | $13M | $9M | |
| Common Stock | $60.0K | $59.0K | $46.0K | $42.0K | $41.0K | $1.0K | |
| Retained Earnings | $-351M | $-238M | $-169M | $-110M | $-47M | $-15M | |
| AOCI | $4M | $2M | $665.0K | $-2M | $-270.0K | $0 | |
| Stockholders' Equity | $957M | $1.02B | $344M | $321M | $366M | $-15M | |
| Liabilities + Equity | $1.00B | $1.06B | $380M | $364M | $380M | $16M | |
| Shares Outstanding | 60,384,283 | 59,064,606 | 46,252,440 | 41,616,260 | 41,243,137 | 1,046,599 |
Flujo de Efectivo 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $40M | $33M | $20M | $17M | $7M | $72.0K | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $-82M | $-44M | $-51M | $-43M | $-17M | $-4M | |
| CapEx | $1M | $359.0K | $2M | $6M | $1M | $0 | |
| Investing Cash Flow | $-301M | $-258M | $-41M | $58M | $-341M | $0 | |
| Financing Cash Flow | $5M | $713M | $60M | $500.0K | $387M | $12M | |
| Free Cash Flow | $-83M | $-44M | $-52M | $-49M | $-18M | · |
Rentabilidad 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -1576.7% | -933.6% | -902.9% | -779.0% | -905.4% | · | |
| Net Margin | -1136.2% | -651.6% | -721.2% | -732.2% | -898.3% | · | |
| EBITDA Margin | -1576.7% | -933.6% | -902.9% | -779.0% | -905.4% | · | |
| ROA | -11.0% | -9.6% | -15.7% | -17.0% | -16.5% | · | |
| ROE | -11.7% | -8.2% | -16.8% | -19.3% | -8.8% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 39.0 | 59.2 | 26.8 | 20.1 | 29.5 | · | |
| Quick Ratio | 38.7 | 58.7 | 26.4 | 19.8 | 29.3 | · |
Eficiencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | · | · | · | 0.9 | · |
Tasas de Crecimiento 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -5.5% | 31.0% | -6.1% | 136.8% | · | · | |
| Revenue CAGR 3Y | 5.1% | 42.8% | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $11M | $8M | $9M | $4M | · | |
| Net Income TTM | $-114M | $-69M | $-58M | $-63M | $-33M | · | |
| Market Cap | $833M | $3.16B | $496M | $548M | $814M | · | |
| P/E | -7.5 | -41.8 | -8.1 | -8.7 | -14.2 | · | |
| P/S | 83.3 | 298.7 | 61.4 | 63.6 | 223.7 | · | |
| P/B | 0.9 | 3.1 | 1.4 | 1.7 | 2.2 | · | |
| P / Tangible Book | 0.9 | 3.1 | 1.4 | 1.7 | 2.2 | · | |
| P / Cash Flow | -10.1 | -72.2 | -9.8 | -12.8 | -47.9 | · | |
| P / FCF | -10.0 | -71.6 | -9.5 | -11.1 | -44.1 | · | |
| Earnings Yield | -13.3% | -2.4% | -12.3% | -11.5% | -7.0% | · |
Estado de resultados 11
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | $4M | $0 | $10M | $0 | $0 | $0 | $439.0K | $9M | $1M | $3M | $1M | $2M | $2M | $2M | $2M | |
| R&D Expense | $31M | $27M | $32M | $35M | $35M | $25M | $21M | $19M | $15M | $14M | $12M | $15M | $16M | $14M | $14M | $10M | |
| SG&A Expense | $11M | $11M | $11M | $11M | $10M | $10M | $8M | $18M | $8M | $7M | $6M | $7M | $6M | $6M | $6M | $5M | |
| Operating Income | $-32M | $-34M | $-42M | $-35M | $-45M | $-35M | $-29M | $-36M | $-14M | $-20M | $-16M | $-21M | $-20M | $-18M | $-17M | $-14M | |
| Other Non-op | $10M | $10M | $10M | $11M | $11M | $11M | $9M | $8M | $8M | $5M | $4M | $3M | $3M | $1M | $373.0K | $132.0K | |
| Net Income | $-22M | $-24M | $-32M | $-24M | $-34M | $-24M | $-20M | $-28M | $-6M | $-15M | $-12M | $-18M | $-17M | $-17M | $-17M | $-13M | |
| EPS (Basic) | $-0.35 | $-0.39 | $-0.51 | $-0.39 | $-0.55 | $-0.38 | $-0.36 | $-0.51 | $-0.11 | $-0.30 | $-0.25 | $-0.42 | $-0.42 | $-0.40 | $-0.41 | $-0.32 | |
| EPS (Diluted) | $-0.35 | $-0.39 | $-0.51 | $-0.39 | $-0.55 | $-0.38 | $-0.36 | $-0.51 | $-0.11 | $-0.30 | $-0.25 | $-0.42 | $-0.42 | $-0.40 | $-0.41 | $-0.32 | |
| Shares (Basic) | 62,937,295 | 62,665,717 | -123,750,818 | 62,023,685 | 61,902,411 | 61,791,721 | -104,378,597 | 54,628,670 | 54,451,666 | 49,049,741 | 45,708,649 | 41,836,238 | 41,763,971 | 41,526,524 | 41,448,743 | 41,315,482 | |
| Shares (Diluted) | 62,937,295 | 62,665,717 | -123,750,818 | 62,023,685 | 61,902,411 | 61,791,721 | -104,378,597 | 54,628,670 | 54,451,666 | 49,049,741 | 45,708,649 | 41,836,238 | 41,763,971 | 41,526,524 | 41,448,743 | 41,315,482 | |
| EBITDA | $-32M | $-34M | · | $-35M | $-45M | $-35M | · | $-36M | $-14M | $-20M | $-16M | $-21M | $-20M | $-18M | $-17M | $-14M |
Balance general 21
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28M | $52M | $52M | $48M | $52M | $74M | $431M | $27M | $15M | $213M | $17M | $34M | $30M | $65M | $58M | $55M | |
| Short-term Investments | $943M | $905M | $914M | $941M | $944M | $940M | $595M | $631M | $632M | $439M | $333M | $270M | $287M | $274M | $296M | $306M | |
| Receivables | $149.0K | $35M | · | · | · | · | · | · | $8M | $519.0K | $0 | $0 | $750.0K | $500.0K | $0 | $0 | |
| Prepaid Expense | $12M | $11M | $9M | $9M | $10M | $9M | $8M | $8M | $8M | $6M | $5M | $6M | $4M | $5M | $4M | $3M | |
| Current Assets | $983M | $1.00B | $976M | $998M | $1.01B | $1.02B | $1.03B | $666M | $662M | $659M | $355M | $309M | $321M | $344M | $358M | $365M | |
| PP&E (Net) | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $7M | $7M | $7M | $7M | $7M | $4M | $3M | |
| PP&E (Gross) | $11M | $11M | $11M | $11M | $11M | $10M | $10M | $10M | $10M | $10M | $10M | $9M | $9M | $7M | $4M | $3M | |
| Accum. Depreciation | $8M | $7M | $7M | $6M | $6M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $1M | $567.0K | $320.0K | $212.0K | |
| Other Non-current Assets | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $207.0K | $337.0K | |
| Total Assets | $1.01B | $1.03B | $1.00B | $1.02B | $1.03B | $1.05B | $1.06B | $695M | $691M | $689M | $387M | $342M | $353M | $376M | $385M | $369M | |
| Accounts Payable | $3M | $3M | $5M | $3M | $3M | $2M | $4M | $2M | $1M | $2M | $3M | $2M | $2M | $3M | $3M | $2M | |
| Accrued Liabilities | $20M | $15M | $18M | $22M | $16M | $13M | $12M | $13M | $9M | $6M | $7M | $9M | $8M | $7M | $4M | $5M | |
| Current Liabilities | $60M | $59M | $25M | $28M | $21M | $18M | $17M | $17M | $12M | $11M | $14M | $18M | $16M | $16M | $13M | $13M | |
| Capital Leases | $18M | $19M | $20M | $20M | $20M | $21M | $21M | $22M | $22M | $23M | $23M | $24M | $24M | $24M | $23M | $0 | |
| Total Liabilities | $80M | $87M | $45M | $48M | $42M | $38M | $39M | $39M | $34M | $33M | $38M | $42M | $42M | $44M | $42M | $13M | |
| Common Stock | $61.0K | $60.0K | $60.0K | $60.0K | $59.0K | $59.0K | $59.0K | $52.0K | $52.0K | $51.0K | $46.0K | $42.0K | $42.0K | $42.0K | $42.0K | $41.0K | |
| Retained Earnings | $-398M | $-376M | $-351M | $-319M | $-295M | $-261M | $-238M | $-218M | $-189M | $-184M | $-157M | $-145M | $-128M | $-94M | $-78M | $-61M | |
| AOCI | $-2M | $576.0K | $4M | $5M | $4M | $4M | $2M | $8M | $-2M | $-524.0K | $-1M | $-1M | $-739.0K | $-2M | $-2M | $-2M | |
| Stockholders' Equity | $928M | $942M | $957M | $977M | $991M | $1.01B | $1.02B | $656M | $658M | $656M | $349M | $299M | $311M | $332M | $344M | $356M | |
| Liabilities + Equity | $1.01B | $1.03B | $1.00B | $1.02B | $1.03B | $1.05B | $1.06B | $695M | $691M | $689M | $387M | $342M | $353M | $376M | $385M | $369M | |
| Shares Outstanding | 61,077,980 | 60,865,458 | 60,384,283 | 60,123,602 | 59,297,814 | 59,168,490 | 59,064,606 | 52,337,239 | 52,162,215 | 51,840,571 | 46,151,427 | 41,867,536 | 41,802,807 | 41,550,704 | 41,501,269 | 41,393,660 |
Flujo de Efectivo 6
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $9M | $10M | $9M | $11M | $11M | $6M | $15M | $6M | $6M | $5M | $6M | $5M | $5M | $4M | $4M | |
| Operating Cash Flow | $12M | $-12M | $-29M | $-13M | $-24M | $-17M | $-17M | $-2M | $-10M | $-15M | $-12M | $-15M | $-14M | $-13M | $-6M | $-12M | |
| CapEx | $202.0K | $273.0K | $106.0K | $93.0K | $473.0K | $371.0K | $42.0K | $25.0K | $95.0K | $197.0K | $470.0K | $580.0K | $285.0K | $3M | $898.0K | $971.0K | |
| Investing Cash Flow | $-39M | $8M | $30M | $8M | $2M | $-340M | $34M | $13M | $-191M | $-114M | $-61M | $18M | $-9M | $20M | $9M | $31M | |
| Financing Cash Flow | $2M | $4M | $3M | $493.0K | $954.0K | $554.0K | $387M | $2M | $3M | $322M | $57M | $528.0K | $2M | $0 | $308.0K | $1.0K | |
| Free Cash Flow | · | $-13M | · | · | · | $-17M | · | · | · | $-15M | · | · | $-14M | · | · | $-12M |
Rentabilidad 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -308.7% | -916.5% | · | -352.5% | · | · | · | -8164.5% | -155.4% | -1610.3% | -628.2% | -1962.9% | -990.3% | -994.0% | -729.9% | -852.2% | |
| Net Margin | -214.0% | -652.6% | · | -243.1% | · | · | · | -6391.6% | -67.0% | -1178.9% | -459.6% | -1656.4% | -852.5% | -920.9% | -714.1% | -843.9% | |
| EBITDA Margin | -308.7% | -916.5% | · | -352.5% | · | · | · | -8164.5% | -155.4% | -1610.3% | -628.2% | -1962.9% | -990.3% | -994.0% | -729.9% | -852.2% | |
| ROA | -2.1% | -2.3% | · | -2.8% | -3.9% | -2.7% | · | -5.2% | -1.1% | -2.8% | -3.0% | -4.8% | -4.8% | -4.3% | -4.3% | -7.3% | |
| ROE | -2.3% | -2.5% | · | -3.0% | -4.1% | -2.8% | · | -5.6% | -1.2% | -3.0% | -3.4% | -5.4% | -5.2% | -4.7% | -4.6% | -7.5% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.3 | 17.0 | · | 35.9 | 47.0 | 58.5 | · | 38.8 | 57.3 | 62.1 | 24.5 | 17.3 | 19.9 | 21.1 | 27.6 | 29.1 | |
| Quick Ratio | 16.1 | 16.8 | · | 35.5 | 46.6 | 57.9 | · | 38.3 | 56.6 | 61.5 | 24.2 | 16.9 | 19.7 | 20.8 | 27.3 | 28.9 |
Eficiencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 2.7 | 0.2 | · | · | · | · | · | · | 2.4 | 2.0 | 10.1 | · | 5.5 | 7.3 | 12.6 | · |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $24M | $14M | · | $10M | $9M | $11M | · | $13M | $14M | $7M | $7M | $7M | $8M | $7M | $6M | $4M | |
| Net Income TTM | $-105M | $-106M | · | $-110M | $-91M | $-72M | · | $-60M | $-50M | $-61M | $-63M | $-69M | $-64M | $-58M | $-47M | $-33M | |
| Market Cap | $938M | $846M | · | $1.47B | $1.37B | $1.60B | · | $2.38B | $2.19B | $1.95B | $465M | $497M | $506M | $563M | $507M | $594M | |
| P/E | -9.1 | -8.1 | · | -13.4 | -14.9 | -20.8 | · | -38.8 | -38.8 | -27.1 | -6.8 | -7.2 | -7.8 | -9.7 | -7.6 | · | |
| P/S | 39.1 | 61.6 | · | 140.8 | 146.7 | 150.9 | · | 181.4 | 159.2 | 283.9 | 62.6 | 68.2 | 64.7 | 81.2 | 90.6 | 164.4 | |
| P/B | 1.0 | 0.9 | · | 1.5 | 1.4 | 1.6 | · | 3.6 | 3.3 | 3.0 | 1.3 | 1.7 | 1.6 | 1.7 | 1.5 | 1.7 | |
| P / Tangible Book | 1.0 | 0.9 | · | 1.5 | 1.4 | 1.6 | · | 3.6 | 3.3 | 3.0 | 1.3 | 1.7 | 1.6 | 1.7 | 1.5 | 1.7 | |
| P / Cash Flow | · | -68.6 | · | · | · | -93.8 | · | · | · | -131.5 | · | · | -36.4 | · | · | -51.5 | |
| P / FCF | · | -67.1 | · | · | · | -91.8 | · | · | · | -129.8 | · | · | -35.6 | · | · | -47.5 | |
| Earnings Yield | -10.9% | -12.3% | · | -7.5% | -6.7% | -4.8% | · | -2.6% | -2.6% | -3.7% | -14.8% | -13.9% | -12.8% | -10.3% | -13.2% | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $10M | $11M | $8M | $9M | $4M |
| Margen Operativo % | -1576.7% | -933.6% | -902.9% | -779.0% | -905.4% |
| Beneficio neto | $-114M | $-69M | $-58M | $-63M | $-33M |
| EPS Diluido | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 39.0 | 59.2 | 26.8 | 20.1 | 29.5 |
| Ratio Rápido | 38.7 | 58.7 | 26.4 | 19.8 | 29.3 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-83M | $-44M | $-52M | $-49M | $-18M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 216 declarantes · $815.3M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 46 (+5 vs trimestre anterior) | 28 (0 vs trimestre anterior) | 77 (+9 vs trimestre anterior) | 47 (-5 vs trimestre anterior) | +785K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $171 873 684 | 11 189 693 | 21,08% | Acciones |
| Prosight Management, LP | $58 436 828 | 3 804 481 | 7,17% | Acciones |
| JANUS HENDERSON GROUP PLC | $57 850 010 | 4 165 432 | 7,10% | Acciones |
| STATE STREET CORP | $46 155 249 | 3 004 899 | 5,66% | Acciones |
| VANGUARD GROUP INC | $35 180 174 | 2 549 288 | 4,32% | Acciones |
| Point72 Asset Management, L.P. | $30 625 336 | 1 993 837 | 3,76% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $28 528 911 | 1 857 351 | 3,50% | Acciones |
| TCG Crossover Management, LLC | $27 488 517 | 1 789 617 | 3,37% | Acciones |
| Alyeska Investment Group, L.P. | $25 300 070 | 1 647 140 | 3,10% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20 439 706 | 1 330 710 | 2,51% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $18 543 360 | 1 207 250 | 2,27% | Acciones |
| FMR LLC | $18 439 419 | 1 200 483 | 2,26% | Acciones |
| ALGERT GLOBAL LLC | $17 063 255 | 1 110 889 | 2,09% | Acciones |
| D. E. Shaw & Co., Inc. | $16 842 378 | 1 096 509 | 2,07% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $16 009 820 | 1 042 306 | 1,96% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $15 824 854 | 1 030 000 | 1,94% | Acciones |
| GOLDMAN SACHS GROUP INC | $12 850 084 | 836 594 | 1,58% | Acciones |
| Nantahala Capital Management, LLC | $12 440 279 | 809 914 | 1,53% | Acciones |
| BANK OF AMERICA CORP /DE/ | $11 710 018 | 762 371 | 1,44% | Acciones |
| Qube Research & Technologies Ltd | $10 783 596 | 702 057 | 1,32% | Acciones |
| Squarepoint Ops LLC | $8 176 451 | 532 321 | 1,00% | Acciones |
| ORBIMED ADVISORS LLC | $8 059 392 | 524 700 | 0,99% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $7 749 796 | 504 544 | 0,95% | Acciones |
| ADAR1 Capital Management, LLC | $6 464 732 | 420 881 | 0,79% | Acciones |
| Cubist Systematic Strategies, LLC | $6 293 960 | 257 527 | 0,77% | Acciones |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | $5 782 979 | 376 496 | 0,71% | Acciones |
| Woodline Partners LP | $5 683 692 | 370 032 | 0,70% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $5 670 774 | 369 191 | 0,70% | Acciones |
| Rock Springs Capital Management LP | $5 637 258 | 367 009 | 0,69% | Acciones |
| Jump Financial, LLC | $5 555 174 | 361 665 | 0,68% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $5 393 265 | 351 124 | 0,66% | Acciones |
| BlackRock, Inc. | $5 070 812 | 330 131 | 0,62% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $4 842 563 | 315 271 | 0,59% | Acciones |
| CITADEL ADVISORS LLC | $4 480 497 | 291 699 | 0,55% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $4 133 576 | 269 113 | 0,51% | Acciones |
| Man Group plc | $3 821 583 | 248 801 | 0,47% | Acciones |
| Balyasny Asset Management L.P. | $3 250 714 | 211 635 | 0,40% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $3 219 348 | 209 593 | 0,39% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $3 018 040 | 196 487 | 0,37% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 403 840 | 156 500 | 0,29% | Opción de venta |
| BML Capital Management, LLC | $2 380 201 | 154 961 | 0,29% | Acciones |
| Springhill Fund Asset Management (HK) Co Ltd | $2 119 500 | 78 500 | 0,26% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $2 018 565 | 131 417 | 0,25% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 744 896 | 113 600 | 0,21% | Opción de compra |
| FEDERATED HERMES, INC. | $1 719 537 | 111 949 | 0,21% | Acciones |
| CAPITAL FUND MANAGEMENT S.A. | $1 566 289 | 101 972 | 0,19% | Acciones |
| Rangeley Capital, LLC | $1 504 942 | 97 978 | 0,18% | Acciones |
| TWO SIGMA ADVISERS, LP | $1 436 580 | 104 100 | 0,18% | Acciones |
| WINTON GROUP Ltd | $1 387 008 | 90 300 | 0,17% | Acciones |
| AVALON VENTURES MANAGEMENT, LLC | $1 302 652 | 53 300 | 0,16% | Acciones |
| Swiss National Bank | $1 218 048 | 79 300 | 0,15% | Acciones |
| XTX Topco Ltd | $1 186 299 | 77 233 | 0,15% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1 177 000 | 76 601 | 0,14% | Acciones |
| JANE STREET GROUP, LLC | $1 167 252 | 75 993 | 0,14% | Acciones |
| JANE STREET GROUP, LLC | $1 165 824 | 75 900 | 0,14% | Opción de compra |
| Quantinno Capital Management LP | $1 078 840 | 70 237 | 0,13% | Acciones |
| CITIGROUP INC | $1 040 486 | 67 740 | 0,13% | Acciones |
| CONGRESS ASSET MANAGEMENT CO | $1 038 490 | 67 610 | 0,13% | Acciones |
| Trexquant Investment LP | $973 133 | 63 355 | 0,12% | Acciones |
| Walleye Capital LLC | $957 512 | 62 338 | 0,12% | Acciones |
| Raiffeisen Bank International AG | $919 500 | 60 000 | 0,11% | Acciones |
| BARCLAYS PLC | $899 528 | 58 563 | 0,11% | Acciones |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $860 160 | 56 000 | 0,11% | Acciones |
| RHUMBLINE ADVISERS | $848 184 | 55 221 | 0,10% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $847 344 | 60 960 | 0,10% | Acciones |
| Rafferty Asset Management, LLC | $823 419 | 53 608 | 0,10% | Acciones |
| Bank of New York Mellon Corp | $780 595 | 50 820 | 0,10% | Acciones |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $749 169 | 48 774 | 0,09% | Acciones |
| HighVista Strategies LLC | $743 056 | 48 376 | 0,09% | Acciones |
| AXQ CAPITAL, LP | $729 723 | 47 508 | 0,09% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $713 871 | 46 476 | 0,09% | Acciones |
| Engineers Gate Manager LP | $696 008 | 45 313 | 0,09% | Acciones |
| HSBC HOLDINGS PLC | $686 212 | 44 101 | 0,08% | Acciones |
| DEUTSCHE BANK AG\ | $664 750 | 43 278 | 0,08% | Acciones |
| Jain Global LLC | $636 349 | 41 429 | 0,08% | Acciones |
| Verdad Advisers, LP | $620 329 | 40 386 | 0,08% | Acciones |
| Schonfeld Strategic Advisors LLC | $616 871 | 40 161 | 0,08% | Acciones |
| CITADEL ADVISORS LLC | $589 824 | 38 400 | 0,07% | Opción de compra |
| FRANKLIN RESOURCES INC | $577 060 | 37 569 | 0,07% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $514 314 | 37 001 | 0,06% | Acciones |
| TEMA ETFS LLC | $511 870 | 37 092 | 0,06% | Acciones |
| MARSHALL WACE, LLP | $502 794 | 32 734 | 0,06% | Acciones |
| MARTINGALE ASSET MANAGEMENT L P | $475 807 | 30 977 | 0,06% | Acciones |
| Hudson Bay Capital Management LP | $460 800 | 30 000 | 0,06% | Acciones |
| Walleye Capital LLC | $459 264 | 29 900 | 0,06% | Opción de compra |
| CenterBook Partners LP | $437 791 | 28 502 | 0,05% | Acciones |
| TUDOR INVESTMENT CORP ET AL | $431 155 | 28 070 | 0,05% | Acciones |
| PROFUND ADVISORS LLC | $414 305 | 26 973 | 0,05% | Acciones |
| Entropy Technologies, LP | $411 571 | 26 795 | 0,05% | Acciones |
| MetLife Investment Management, LLC | $399 836 | 26 031 | 0,05% | Acciones |
| CITADEL ADVISORS LLC | $394 752 | 25 700 | 0,05% | Opción de venta |
| VANGUARD ASSET MANAGEMENT, Ltd | $375 383 | 24 439 | 0,05% | Acciones |
| Virtus Investment Advisers, LLC | $370 637 | 24 130 | 0,05% | Acciones |
| Point72 (DIFC) Ltd | $370 046 | 15 141 | 0,05% | Acciones |
| Aigen Investment Management, LP | $350 838 | 22 841 | 0,04% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $305 818 | 19 910 | 0,04% | Acciones |
| Bleakley Financial Group, LLC | $305 649 | 19 899 | 0,04% | Acciones |
| Vanguard Global Advisers, LLC | $303 805 | 19 779 | 0,04% | Acciones |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $302 362 | 19 685 | 0,04% | Acciones |
| Lion Point Capital, LP | $291 840 | 19 000 | 0,04% | Acciones |
Informantes de la empresa 21 insiders · 9 directivos · 12 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| David Alan Campbell | President and CEO | 31 de julio de 2026 G | 264 742 | 0 | 0 | $0 |
| Tighe Reardon | Acting Chief Financial Officer | 2 de enero de 2024 A | 849 854 | 0 | 0 | $0 |
| Janeen Noel Doyle | Chief Corp. & Bus. Dev. Ofcr | 2 de junio de 2026 S | 75 941 | 0 | 1 | $-56 944 |
| Thomas Diraimondo | Chief Scientific Officer | 2 de enero de 2024 A | — | 0 | 0 | $0 |
| Charles M. Winter | Chief Technical Officer | 2 de enero de 2024 A | — | 0 | 0 | $0 |
| Byron Robinson | Chief Strategy Officer | 2 de enero de 2024 A | — | 0 | 0 | $0 |
| Andrew Hollman Meyer | Chief Business Officer | 2 de enero de 2024 A | — | 0 | 0 | $0 |
| Wayne Godfrey | Chief Medical Officer | 3 de enero de 2023 A | — | 0 | 0 | $0 |
| Shahram Salek-Ardakani | Chief Scientific Officer | 3 de enero de 2022 A | — | 0 | 0 | $0 |
| Jake Simson | Consejero | 11 de junio de 2026 A | 11 750 | 0 | 0 | $0 |
| Natasha Hernday | Consejero | 11 de junio de 2026 A | 15 481 | 0 | 0 | $0 |
| Winston Kung | Consejero | 11 de junio de 2026 A | 11 750 | 0 | 0 | $0 |
| Ronald W Barrett | Consejero | 11 de junio de 2026 A | 11 750 | 0 | 0 | $0 |
| Vickie L Capps | Consejero | 11 de junio de 2026 A | 79 598 | 0 | 0 | $0 |
| Eric Dobmeier | Consejero | 11 de junio de 2026 A | 15 481 | 0 | 0 | $0 |
| Jay Lichter | Consejero | 13 de noviembre de 2023 P | 849 854 | 0 | 0 | $0 |
| Alana B. Mcnulty | Consejero | 14 de junio de 2023 A | — | 0 | 0 | $0 |
| Sheila Gujrathi | Consejero | 14 de junio de 2023 A | — | 0 | 0 | $0 |
| Stefan Heller | Consejero | 14 de junio de 2022 A | — | 0 | 0 | $0 |
| Peter A. Thompson | Consejero | 14 de junio de 2022 A | 231 098 | 0 | 0 | $0 |
| Bregua Corp | Propietario del 10% | 15 de junio de 2021 C | 3 749 250 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 4 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 presentaciones | 10 de marzo de 2025 | 19,90% | Enmienda | — | SEC |
| Avalon Ventures XI, L.P., Avalon BioVentures SPV I, L.P., Avalon BioVentures I, LP, Avalon Ventures XI GP LLC, ABV SPV I GP LLC, Avalon BioVentures GP, LLC, Kevin Kinsella, Richard Levandov, Braden Bohrmann, Jay Lichter, Ph.D., Tighe Reardon, Sergio G. Duron, Ph.D., Sanford Madigan, Ph.D. ×6 presentaciones | 8 de noviembre de 2024 | — | Presentación inicial | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VIII LLC, OrbiMed Genesis GP LLC, OrbiMed Capital LLC ×3 presentaciones | 9 de agosto de 2024 | — | Presentación inicial | — | SEC |
| Avalon Ventures XI, L.P. (“Avalon Ventures”), Avalon BioVentures SPV I, L.P. (“ABV SPV”), Avalon Bioventures I, LP (“ABV I”), Avalon Ventures XI GP LLC (“Avalon XI GP”), ABV SPV I GP LLC (“ABV SPV GP”), Avalon BioVentures GP, LLC (“ABV GP”), Kevin Kinsella (“Kinsella”), Richard Levandov (“Levandov”), Braden Bohrmann (“Bohrmann”), Jay Lichter, Ph.D. (“Lichter”), Tighe Reardon (“Reardon”), Sergio Duron (“Duron”), Sanford Madigan, Ph.D. (“Madigan”) ×2 presentaciones | 16 de noviembre de 2023 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 41 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IDNA · iShares Trust | 1,01% | 124 166 SH | 8 de agosto de 2026 | Diario |
| BBC · ETFis Series Trust I | 0,69% | 18 038 NS | 30 de abril de 2026 | N-PORT |
| CANC · Tema ETF Trust | 0,43% | 51 522 NS | 31 de mayo de 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 0,42% | 11 754 NS | 31 de mayo de 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,33% | 62 348 NS | 31 de mayo de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,23% | 81 512 NS | 30 de abril de 2026 | N-PORT |
| ESSC · Strategy Shares | 0,12% | 2 106 NS | 30 de abril de 2026 | N-PORT |
| IBB · iShares Trust | 0,07% | 423 011 SH | 8 de agosto de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,07% | 3 319 SH | 8 de agosto de 2026 | Diario |
| BIB · ProShares Trust | 0,04% | 2 251 NS | 31 de mayo de 2026 | N-PORT |
| IWN · iShares Trust | 0,04% | 401 400 SH | 8 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 37 644 SH | 8 de agosto de 2026 | Diario |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,03% | 14 865 NS | 30 de abril de 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 9 972 SH | 8 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,02% | 1 104 928 SH | 8 de agosto de 2026 | Diario |
| SMLF · iShares Trust | 0,02% | 53 265 SH | 8 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 248 060 SH | 8 de agosto de 2026 | Diario |
| TECB · iShares Trust | 0,02% | 5 624 SH | 8 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,02% | 18 584 NS | 30 de abril de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 31 889 SH | 8 de agosto de 2026 | Diario |
| ITWO · ProShares Trust | 0,02% | 2 017 NS | 31 de mayo de 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 28 040 NS | 31 de mayo de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 229 332 NS | 31 de mayo de 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 2 013 SH | 8 de agosto de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 552 164 SH | 8 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 117 899 SH | 8 de agosto de 2026 | Diario |
| UWM · ProShares Trust | 0,01% | 1 578 NS | 31 de mayo de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 17 660 NS | 30 de abril de 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 1 594 NS | 31 de mayo de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 62 209 NS | 30 de abril de 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2 543 SH | 8 de agosto de 2026 | Diario |
| DXUV · Dimensional ETF Trust | 0,00% | 1 318 NS | 30 de abril de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1 827 NS | 31 de mayo de 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 40 NS | 31 de mayo de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 68 791 SH | 8 de agosto de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 13 511 SH | 8 de agosto de 2026 | Diario |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 27 817 NS | 31 de mayo de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 154 NS | 30 de abril de 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 696 NS | 31 de mayo de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 263 837 SH | 8 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 110 SH | 8 de agosto de 2026 | Diario |